DV Biomed , Ltd.'s receivables is $35M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), 6539.TWO shows a receivables of $35M. That compares with $34M in the prior-year period — up 3.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, 6539.TWO's receivables is now $35M (was $34M) — a 3.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether DV Biomed , Ltd. is outperforming or lagging.
Tracking 6539.TWO's receivables over time shows whether DV Biomed , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $35M That compares with $34M in the prior-year period — up 3.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this receivables page, Stockcircle has DV Biomed , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $35M) with ownership activity and broader fundamentals.